Selected Publication:
Höfler, H; Ruhri, C; Pütz, B; Wirnsberger, G; Hauser, H.
Oncogene expression in endocrine pancreatic tumors.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1988; 55(6):355-361
Doi: 10.1007/BF02896594
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
-
Hauser Hubert
-
Wirnsberger Gerhard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The mRNA expression of the (proto)oncogenes Ha-ras, Ki-ras, fos, c-myc, N-myc, and sis was studied in five pancreatic endocrine tumors and two non-neoplastic pancreatic tissues. Compared with non-tumorous pancreatic tissue, Ha-ras and Ki-ras mRNA was overexpressed up to 42-fold in all the tumors; metastasizing tumors showed 2-6 times higher Ha-ras mRNA levels than benign neoplasias. In contrast, c-myc mRNA levels were higher in normal tissue than n tumors and fos mRNA levels did not differ significantly between tumors and normal tissue. The activities of Ki-ras, fos and c-myc mRNA expression did not correlate with any of the histological or biological properties of the tumors, nor with the clinical course of disease. Our results, although based on a limited number of cases, suggest tha Ha-ras and Ki-ras mRNA overexpression is associated with the development of pancreatic endocrine tumors. The measurement of Ha-ras mRNA levels may contribute to the assessment of tumor prognosis.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Female -
-
Gene Expression Regulation -
-
Humans -
-
Male -
-
Middle Aged -
-
Nucleic Acid Hybridization -
-
Oncogenes -
-
Pancreatic Neoplasms - genetics
-
Proto-Oncogenes - genetics
-
RNA Probes - genetics
-
RNA, Messenger - genetics